Annexin Pharmaceuticals AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was SEK 12.46 million compared to SEK 10.1 million a year ago. Basic loss per share from continuing operations was SEK 0.04 compared to SEK 0.06 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.285 SEK | -4.04% | +5.17% | +9.62% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.62% | 9.39M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- ANNX Stock
- News Annexin Pharmaceuticals AB
- Annexin Pharmaceuticals AB Reports Earnings Results for the First Quarter Ended March 31, 2024